MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway. (Q48837549)

16 February 2018

title

MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway. (English)

1 reference

16 February 2018

author name string

Li Hong

1

1 reference

16 February 2018

Liu Ya-Wei

2

1 reference

16 February 2018

Wang Hai

3

1 reference

16 February 2018

Zhou Qiang

4

1 reference

16 February 2018

Li Jun-Jie

5

1 reference

16 February 2018

Annie Huang

6

1 reference

16 February 2018

Qi Song-Tao

7

1 reference

16 February 2018

Lu Yun-Tao

8

1 reference

16 February 2018

publication date

12 March 2016

1 reference

16 February 2018

Journal of Neuro-Oncology

published in

1 reference

16 February 2018

volume

128

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

35-45

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-016-2095-z

exact match

0 references

cites work

Angiogenesis in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Molecular pathology of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Proteome-wide discovery of mislocated proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Stat3 activation is required for the growth of U87 cell-derived tumours in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

miR-519 suppresses tumor growth by reducing HuR levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Identification of mammalian microRNA host genes and transcription units

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Nix protein positively regulates NF-κB activation in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

The brain tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Deadly teamwork: neural cancer stem cells and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

The dark side of a success story: microRNAs of the C19MC cluster in human tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

The two faces of Janus kinases and their respective STATs in mammary gland development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

STAT3 tyrosine phosphorylation influences survival in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Regulators of G1 cyclin-dependent kinases and cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Human chorionic gonadotropin β induces cell motility via ERK1/2 and MMP-2 activation in human glioblastoma U87MG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2095-Z

Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26970980

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-016-2095-Z

1 reference

16 February 2018

PubMed ID

26970980

1 reference

16 February 2018